Day One Biopharmaceuticals, Inc.
DAWNDelisted Apr 23, 2026- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001845337
Day One Biopharmaceuticals, Inc. was delisted on Apr 23, 2026; its insiders filed their last Form 4 on Apr 27, 2026; 208 institutions reported holding it in 13F filings for Q1 2026, worth $1.85B in total; Soros Fund Management was the only superinvestor holding it.
13F holders, Q3 2022
Institutional positions in Day One Biopharmaceuticals, Inc. as of Sep 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 93
- +7 vs. Q2 2022
- Shares held
- 60.8M
- +1.39M (+2.3%) vs. Q2 2022
- Total value
- $1.21B
- +$149.0M (+14.0%) vs. Q2 2022
- New holders
- 24
- 36 more added
- Sold out
- 17
- 18 more reduced
1 institution that held it in Q2 2022 haven't filed for Q3 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting DAWN on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 1 | $3.55K |
| Q1 2026 | 208 | $1.85B |
| Q4 2025 | 184 | $758.4M |
| Q3 2025 | 173 | $603.5M |
| Q2 2025 | 174 | $561.1M |
| Q1 2025 | 184 | $747.1M |
| Q4 2024 | 164 | $1.19B |
| Q3 2024 | 166 | $1.28B |
| Q2 2024 | 157 | $1.03B |
| Q1 2024 | 148 | $1.20B |
| Q4 2023 | 139 | $1.12B |
| Q3 2023 | 130 | $951.5M |
| Q2 2023 | 140 | $941.0M |
| Q1 2023 | 126 | $818.1M |
| Q4 2022 | 109 | $1.29B |
| Q3 2022 | 93 | $1.21B |
| Q2 2022 | 87 | $1.06B |
| Q1 2022 | 66 | $429.6M |
| Q4 2021 | 58 | $698.3M |
| Q3 2021 | 45 | $452.9M |
| Q2 2021 | 33 | $401.1M |
| Q1 2021 | 0 | $0 |
Institutions, Q3 2022
Shares, value and share of portfolio for each institution holding Day One Biopharmaceuticals, Inc.; share changes are against Q2 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Ergoteles LLC | 0 | $0 | 0.00% | −56,300−100.0% | Sold out |
| Allianz Asset Management GmbH | 0 | $0 | 0.00% | −51,325−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −35,426−100.0% | Sold out |
| Utah Retirement Systems | 0 | $0 | 0.00% | −34,184−100.0% | Sold out |
| Monashee Investment Management LLC | 0 | $0 | 0.00% | −30,000−100.0% | Sold out |
| Occudo Quantitative Strategies LP | 0 | $0 | 0.00% | −23,619−100.0% | Sold out |
| Millennium Management LLC | 0 | $0 | 0.00% | −17,555−100.0% | Sold out |
| Quantbot Technologies LP | 0 | $0 | 0.00% | −2,900−100.0% | Sold out |
| ACG Wealth | 0 | $0 | 0.00% | −1,772−100.0% | Sold out |
| Advisor Group Holdings, Inc. | 0 | $0 | 0.00% | −1−100.0% | Sold out |
| Quintet Private Bank (Europe) S.A. | – | – | – | – | Not filed |